The Lamp Still Shines: The Nightingale Legacy Lives On
An Engine of Medical Progress: Clinical Trials
Avoid Getting Burned: A Look into Deadly Skin Cancer
How to Level Up at Work and Unlock Your Potential
EMPLOYEE SPOTLIGHTS: Katie Butler and Brigette Bellard
"The goal is to ensure our patients feel supported, understood and empowered throughout their journey."
In today’s rapidly evolving healthcare ecosystem, the concept of the Connected Patient Experience is emerging as a pivotal framework for delivering quality-focused, patient-centered healthcare. This is more evident in managing complex chronic conditions like cancer. As we look at the complexities of cancer care, it becomes clear that the needs of cancer patients extend far beyond the clinical management of their disease. How do we define quality as a function of patient expectations and measure the value of those interventions and outcomes?
The narrative focus is on how we continue to forge a pathway toward creating a connected patient experience, recognizing the multifaceted aspects of a patient's life that is inclusive of clinical management, socioeconomic determinants of health, mental health, and overall health and wellness.
From a clinical perspective, personalized medicine and precision oncology have significantly advanced the ability to tailor treatments to individual patients. However, the clinical dimension is just one piece of the puzzle. Cancer patients and their families are faced with navigating a complex journey marked by medical appointments, treatments, and the psychological toll of their diagnosis. This experience is also profoundly shaped by their social environment, mental health and economic stability.
Understanding patients’ significant social challenges, such as maintaining employment, fulfilling family responsibilities and staying connected with their community, are crucial factors to consider for cancer care teams aiming to provide excellent comprehensive care. Social determinants of health, including access to transportation, safe housing and social support, play a critical role in treatment adherence and overall well-being. Institutions must, therefore, integrate social support services, such as social work, community resources and patient navigation, into their care models.
Mental health is often the piece that is intangible at a glance but can manifest itself in ways that impact a cancer patient, leading to anxiety, depression and a sense of isolation. Mental health services, including counseling, support groups and psychiatric care, should seamlessly integrate into the oncology care pathway. Addressing the mental health component should not remain an ancillary piece but rather central to comprehensive cancer care, as emotional resilience can significantly positively influence treatment outcomes and quality of life.
Additionally, the economic burden of cancer care cannot be overlooked as the financial weight is an expense most cannot afford. Patients are often concerned with the direct costs of treatment and indirect costs, such as loss of income and out-of-pocket expenses. Transparent communication about the cost of care, financial counseling and assistance programs are essential in alleviating the financial stress associated with cancer. Institutions need to support patients in navigating insurance complexities and provide resources to manage the economic impact of their diagnosis.
At AON, we recognize that the Connected Patient Experience acknowledges that patients are not just recipients of clinical treatment but are individuals with diverse needs and concerns. A holistic approach entails integrating multidisciplinary teams that collaborate to support the patient through every aspect of their journey. Digital health tools, including patient portals and telemedicine, can enhance connectivity and continuity of care, allowing patients to access information, communicate with their care team and manage their health more effectively. We will continue to be purposeful in measuring the clinical, social, mental and economic impact on a patient’s life to allow us to deliver a more compassionate, effective and comprehensive care experience. The goal is to ensure our patients feel supported, understood and empowered throughout their journey to maximize outcomes and foster a patient-centered healthcare environment.
I invite you to remember this as we continue delivering our patient-first care and services this year. Thank you for your dedication and commitment to the AON mission and our patients.
Alti Rahman, MHA/MBA, CSSBB AON’s Chief Strategy and Innovation Officer
133 CIOs to know | 2024
Feature: Mark Moch
The featured IT executives are leading strategic initiatives that benefit patients and providers.
Learn more
Leveraging Managed Service Organizations to Provide More Affordable, Personalized Cancer Care
Feature: Stephen “Fred” Divers, MD
As the cost of cancer treatment continues to rise for both patients and providers, independent clinicians are being forced to consolidate with larger health care systems to stay financially afloat.
Learn more
Expert: Pharmacists Have Vital Role in Multiple Myeloma Treatment
Feature: Melody Chang, RPh, MBA, BCOP
Pharmacy Times interviewed Melody Chang, RPh, MBA, BCOP, vice president of pharmacy operations, American Oncology Network, about the crucial role that pharmacists play in the treatment and management of multiple myeloma.
Learn more
Is Community Oncology Falling Behind on AI?
Feature: Alti Rahman, MHA/MBA, CSSBB
When it comes to the use of artificial intelligence (AI) in community oncology, “I just don’t think we’re attracting the right attention,” says Alti Rahman, chief strategy and innovation officer at American Oncology Network.
Learn more
The Potential for AI in Oncology
Feature: Jim Chen, MD
In a session at the 2024 Community Oncology Conference titled “Is AI Ready for Prime Time for Cancer Care?”, Jim Chen, MD, American Oncology Network, and Sanjay Doddamani, MD, MBA, Guidehealth, provided an overview of where artificial intelligence (AI) technology stands today and its potential for use in cancer care.
Learn more
‘Sapphires and Speedways’: Fundraising Gala for American Oncology Cares Foundation
Feature: Ruemu E. Birhiray, MD
The hard truth is that many of our fellow Hoosiers are forced to choose between cancer treatment and keeping a roof over their head each and every day.
Learn more
“I Don’t Think Anybody Wants to Play God”: Ethical Questions in Value-Based Oncology Care
Feature: Stephen “Fred” Divers, MD
As value-based care is increasingly incorporated into oncology, ethical questions arise. “I don’t think anybody wants to play God and decide who does and doesn’t receive care,” explains Stephen “Fred” Divers, MD, a medical oncologist in Arkansas with the American Oncology Network and a Community Oncology Alliance (COA) board member.
Learn more
Thyme Care Unveils "Thyme Care Oncology Partners," a Provider-Powered Value-Based Care Model in Partnership with More than 400 Oncologists Nationwide
Feature: Stephen “Fred” Divers, MD
Thyme Care, the leading value-based cancer care enabler, today unveiled Thyme Care Oncology Partners (TCOP), a dedicated platform for oncology practices.
Learn more
In Cancer Care, Building Trust Requires Understanding, Meeting Patients Where They Are
Feature: Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC Ongoing engagement with patients is paramount to ensuring that treatment recommendations are well understood and adhered to, as well as making sure patients trust their provider and share in care decisions.
Learn more
The Value of Patient Navigation Services for Cancer Patients
Feature: Alti Rahman, MHA/MBA, CSSBB
The National Comprehensive Cancer Network (NCCN) held a patient advocacy summit in Washington, DC, to examine patient navigation solutions to the barriers and challenges patients face on their cancer journeys.
Learn more
AON Saves Over $243 Million With High Biosimilar Adoption
Feature: Melody Chang, RPh, MBA, BCOP
High rates of biosimilar uptake in the American Oncology Network (AON) have saved the organization over $243 million between 2020 and 2023, according to Melody Chang, vice president of pharmacy operations at AON.
Learn more
Todd Schonherz Chief Executive Officer
Mark Moch Chief Information Officer
Ryan Olson, MD Medical Director Pathology
Stephen “Fred” Divers, MD Chief Medical Officer
Karen Pilley Chief Revenue Cycle Officer
David Afshar Chief Financial & Operating Officer
Alti Rahman Chief Strategy & Innovation Officer
Anthony Belott Chief Development Officer
Erica Mallon General Counsel
James Gilmore Chief Pharmacy & Clinical Services Officer
Steve Swart Executive Vice President Practice Operations
Kristin Matisziw Chief Compliance & Risk Officer
Messer Executive Vice President Practice Operations
Melody Chang Vice President Pharmacy Operations
Guy Messer Vice President Radiation & Radiology Services
Michael Essik Vice President Finance
Susan Sabo-Wagner Vice President Clinical Innovation
Katie Goodman Vice President Clinical Research
Kyle Hendrickson Vice President Mergers & Acquisitions
Caroline Hewitt Vice President Marketing
McNair Vice President Laboratory Services
The Nightingale Legacy Lives On
"ALady with a lamp shall stand. In the great history of the land, A noble type of good, Heroic Womanhood.” The 1857 poem “Santa Filomena” by Henry Wadsworth Longfellow.
In 1855, Florence Nightingale, the visionary nurse, tirelessly walked down the dimly lit aisle of lined beds occupied with sick and wounded soldiers who had fought during the Crimean War. As she paced down the aisles, she held a lamp with a small flickering flame that guided her way and served as a beacon of comfort and care for those she cared for. It was this act that solidified her legacy as “the Lady with the Lamp.”
Nightingale’s contributions to the nursing profession transcended battlefield care. She championed practices that are witnessed in the modern clinical nurse specialist (CNS) role, and her dedication to delivering evidencebased care earned her the revered title of “mother and founder of modern nursing.”
Even today, over a century later, Nightingale's influence remains. The Nightingale Pledge, the nursing profession’s version of the Hippocratic Oath, is still used in several schools as a way of passage for nursing graduates. Additionally, the iconic painting illustrating her holding her famed lamp is shared countless times during National Nurses Week and is a physical reminder and testament to her enduring legacy.
The nursing profession has flourished due to Nightingale’s contributions. Today, there are more than 100 nursing specialties in the industry, according to Nursing Journal. While they may differ in concentration, each of these specialties centralizes patient-centered care. With approximately 4.7 million registered nurses in the United States alone, nursing remains the largest healthcare profession, as reported by the American Association of Colleges of Nursing.
Each year, National Nurses Week is celebrated and recognizes nurses across all specialties for their dedication and commitment to serving others. Just as Nightingale carried the lamp as she watched over the wounded soldiers, so too do nurses today carry the torch of hope and care, a guiding light for patients in their times of need.
Nurses are often referred to as the “heart of healthcare” or “the backbone of healthcare.” No matter how the profession is referred to, nurses are indispensable. They
become trusted patient advocates and serve as patients’ voices when needed. They monitor patients, administer medications and therapies and provide comfort and emotional support, among other essential duties.
AON nurses are no different in their service and exemplify Nightingale’s principles in the care they provide. With expertise across a wide range of nursing specialties, AON nurses elevate the patient care provided within the clinics. They are instrumental in fulfilling the mission of breaking down barriers and ensuring the highest quality of cancer care remains accessible and convenient through community-based oncology practices.
AON’s nursing teams bring a wealth of knowledge and experience that directly contributes to the exceptional care patients receive throughout their entire healthcare journey. The seven specialized nursing teams at AON play a critical role at every stage:
These nurses specialize in organizing patient care and treatments by incorporating all members of the care team. They help prevent fragmented care and assist in patient transitions from one care area to another.
These nurses leverage competencies of nursing, computer and information sciences to maintain and develop medical data and systems to support the practice of nursing and improve patient care outcomes.
These nurses safely and accurately mix and administer chemotherapeutic drugs to patients while educating patients on related side effects. They also monitor patients during infusions.
Nurse practitioners work alongside the attending physician and can see patients for routine visits, such as prior to chemotherapy visits and for any acute care issues that may arise.
These nurses assist with the mixing of drugs and doublecheck drug doses for accuracy. They also support patients by addressing questions related to their medications.
These nurses provide information about clinical trials, meticulously screen patients for eligibility, obtain informed consent, educate participants on the clinical trial and offer ongoing support throughout the process.
These nurses receive calls from patients regarding symptoms and side effects. They also act as liaisons between the provider and the patient.
Beyond the diverse range of nursing specialties at AON, nurses share a core set of demanding skills that allow them to excel in the complex environments of oncology and patient care. For example, nurses navigate complex medical situations and advanced therapy plans that require critical thinking and quick decision-making under pressure.
Furthermore, the role requires not only physical stamina but also mental and emotional resilience. This demand can lead to burnout, which is common in the profession. Despite these challenges, nurses are highly adaptable, constantly adjusting their approach to specific situations and tailoring care to individual patient needs.
Recognizing burnout — whether physical, mental or emotional — is crucial. While it does start with raising awareness of burnout and allowing for conversations on the issue, there are several ways nurses and practice staff can resolve it and get back to providing quality patient care. Below are several strategies shared by the American Nurses Association.
• Rest and be sure to get the recommended number of hours of sleep per night.
• Talk to someone about it, like a co-worker or family member. Seek professional help when needed.
• Get some exercise because not only does physical activity help reduce stress, but it also improves strength and cardiovascular health.
• Eat healthy nutritious foods.
• Take a break and find time to disconnect.
Nurses are the backbone of the healthcare system. By acknowledging their challenges, supporting their wellbeing and celebrating their achievements beyond the annual National Nurses Week, AON ensures that nurses continue to shine as beacons of hope and healing for patients and families.
Supporting nurses in their highdemand roles is important to ensure that patient care does not waver. National Nurses Week celebrates nurses who have dedicated themselves to tirelessly serving others in need. But their value extends far beyond a single week. We are honored to have exceptional and highly skilled nurses in our clinics. Without their commitment to patient care, our clinics would not be as efficient and successful.”
– Stephen “Fred” Divers, MD AON's Chief Medical Officer
Harnessing the power of advanced data analytics and artificial intelligence, MiBA transforms the landscape of cancer research and care.
By unlocking insights from complex datasets, our innovative solutions accelerate the discovery of targeted therapies and personalized treatments.
MiBA partners with AON to revolutionize oncology. Precision meets expertise, driving outcomes through data that were once unimaginable. Every data point brings us closer to a cure.
Explore our website to learn more. mibanalytics.com
Clinical trials provide groundbreaking opportunities to discover treatments, whether drugs, devices or innovative approaches, for once-insurmountable diseases. These meticulously designed research studies drive medical progress in pursuit of better tomorrows and are constantly being evaluated for human safety. Those who courageously participate in these studies are the cornerstones of medicine as they pave the way for life-saving treatments and improved healthcare outcomes. Without patients’ willingness to participate, critical new treatments would be impossible, and the advancements in medicine would be further delayed.
Clinical trials have a long rich history dating back centuries, and their design and execution have continuously evolved alongside medical advancements. According to the National Institute of Health’s (NIH) article “Evolution of Clinical Research: A History
Before and Beyond James Lind,” the first recorded study dates to biblical times (500 B.C.) and focused on legumes and lemons from a dietary therapy perspective. It was a trial conducted by King Nebuchadnezzar, who analyzed the nourishment these items provided after the 10-day experiment, compared to the other population, which ate only meat and drank wine.
Another popular study mentioned in the NIH article is the 1747 scurvy study by James Lind, who is considered the “first physician to have conducted a controlled clinical trial in the modern era.” As a working surgeon employed on a traveling ship, he was concerned by the high mortality rates of scurvy among the onboard crew. His trial consisted of analyzing 12 sailors who physically exemplified the same symptoms: rotting gums, spots and lassitude, and knee weakness.
He segmented the sailors into groups of two. Each
group was given different items to digest: quart of cider a day, two spoonfuls of vinegar throughout the day, and two oranges and one lemon a day. Lind reported that the latter had the most visible positive impact on the disease, followed by drinking cider, which the popular adage of preventing scurvy with vitamin C derived from. As a result of Lind’s trial, the British Navy eventually required lemon juice to be a part of sailors’ diets, which was later replaced by cheaper lime juice.
Lastly, the word “placebo,” a popular term used widely in research, debuted in the early 1800s. It was defined as “an epithet given to any medicine more to please than benefit the patient” in Hooper’s Medical Dictionary of 1811. The earliest use of a placebo in a trial was in 1863 by American physician Austin Flint, who treated 13 patients diagnosed with rheumatism.
The NIH article explores other firsts in clinical trials: the first double-blind controlled trial for the common cold (1943) and the first randomized curative trial for streptomycin (1946). Clinical trials were eventually leveraged in cancer research. The National Cancer Institute (NCI) conducted the first randomized clinical trial in 1955 for patients with acute leukemia.
Clinical trials provide immense insights into diseases and how best to treat them. Since the earliest of times, the goal has always been to learn if a given treatment is safe and effective for human use. A common misconception of studies is that they are unsafe for participants.
While they do carry risk as with any standard treatment or therapy, there are mandatory guidelines in place that clinical investigators must follow. The NIH’s article “Clinical Research: Benefits, Risks, and Safety” shares that one of these requirements is having an approved protocol that comprehensively outlines every step that will occur. Additionally, other safety requirements are in place:
• The Institutional Review Board must approve all clinical trials that test new treatments for patients in the United States.
• All clinical trials require written informed consent, which discloses to volunteers all risks and potential benefits of the study before participation begins.
• Clinical trials that test new treatments have committees, like a Data and Safety Monitoring Board and Observational Study Monitoring Boards, that constantly monitor the safety of the study.
Clinical trials undergo rigorous analysis and review before being made available to the public, and as mentioned, they follow strict guidelines to continue. NCI outlines the four necessary phases that any study must endure in its article “How Do Clinical Trials Work:”
• Phase 1 and phase 2 test for how the drug should be administered safely, capturing potential side effects and tolerance in a small group of volunteer participants.
• Phase 3 and phase 4 compare the study’s treatment to current standard treatments and then evaluate the side effects, risks and benefits over a longer period of time.
The researchers collect information and data from patients who participate in phases 1 through 3 and report to agencies, like the U.S. Food and Drug Administration (FDA), which make decisions about treatment approvals based on the data.
Adapted from the AON blog article
Patient participation is key to ensuring the efficacy and accuracy of clinical trials. However, patients aren’t as willing to enroll in trials as they have been in the past. One study conducted in 2020 by the Center for Information and Study on Clinical Research Participation (CISCRP) found that 49% of respondents were willing to participate in trials, which was down from 85% in 2019. One reason could be patient education; that same study showed that 36% of those polled didn’t understand clinical research very well or at all. That number was 10% in 2019.
Community oncology practices' participation in trials can ease the burdens of clinical trial participation by providing patients with access close to home and without travel requirements. This also allows them to participate in trials alongside nurses and physicians they already know and trust.
About 90% of cancer patients are treated at community practices, yet most clinical trials are performed at academic institutions, where they can be accessed by only about 10% of patients. This not only limits the number of patients who can enroll but also puts the additional burden of travel on those who do participate, especially those who live in rural areas.
By administering trials at community oncology practices such as those within AON, patients can access cutting-edge and innovative therapies and medications in the comfort and familiarity of their local clinic.
This benefits scientists and oncologists, too, as they can get a clearer picture of the efficacy of a certain medication or therapy when many patients enroll in a trial.
Patients undergo a rigorous screening process before enrolling in a clinical trial to ensure their safety.
Once patients are cleared, scientists, oncologists and nurses outline the process, explaining why the design of
a certain drug fits their case and how it may aid in their treatment. If a patient has any concerns — for example, understanding potential side effects of the investigational treatment — it is covered in that discussion.
Once those conversations occur and questions are fully addressed, patients are typically very willing and engaged in the trials — especially when they realize their participation can help millions of others who are also fighting cancer.
To read other AON blog articles, visit AONcology.com/blog.
AON is proud to support clinical trials across the country. At least thirteen AON practices participate in clinical research, and four are designated strategic research sites for the Sarah Cannon Research Institute. The practices in the network also offer patients over 150 clinical trials, which are conveniently accessible locally so that they can receive the latest treatments close to home. An Engine of
13 practices participating in clinical research
4 designated Sarah Cannon Research Institute strategic research sites
150+ clinical trials offered
AON’s infrastructure streamlines the clinical trial process, enabling independent practices to contribute to advancing cancer therapies. AON not only supports the heavy lifting on the administrative side through centralized regulatory and data operations but also supplies expertise and technology to help practices host more complex and, ultimately, more successful trials.
One of AON’s most unique assets to its practices is the ability to match a patient’s health data with a specific clinical trial’s eligibility criteria. The organization uses technology to help identify patients who match a study’s criteria and would potentially benefit most from participating. For example, using EHRs and other systems enables the team to match patients with trials based on criteria such as molecular defects or a change in tumor type.
Additionally, AON can help practices conduct their own trials, regardless of size, and help build their research programs. Regarding community trials, working with AON provides access to over 35 years of expertise to assist in this area.
Clinical trials bridge the gap between theoretical promise and real-world application, offering hope for patients and vital data for improving healthcare and patient care. While navigating the complexities of a clinical trial can require careful consideration, the potential rewards for patients, their families and physicians are undeniable. As research evolves and advances, clinical trials will remain at the forefront of unlocking new breakthroughs, ensuring many a brighter and healthier future.
AON celebrates the power of patient stories, and your patients have stories of strength and hope. Featuring your patients showcases the positive impact your practice and physicians make, strengthens your reputation as a leader in compassionate cancer care in the community and provides a source of inspiration and courage for other patients.
We are always seeking stories! Email Marketing@AONcology.com to learn more about how to request a patient story.
Skin cancer is one of the most common cancers diagnosed in the United States, with more than 1 million Americans living with melanoma, the most dangerous type of skin cancer, according to the American Academy of Dermatology (AAD).
Additionally, it is estimated that one in five Americans will develop skin cancer in their lifetime. While this may or may not be a startling statistic, it illustrates the importance of preventive care and early detection.
Regularly examining your skin for any changes can help identify potential cancer and lead you to a dermatologist for analysis and then an oncologist for high-risk and advanced cases. The Centers for Disease Control and Prevention recommends following the A-B-C-D-Es of skin cancer.
A
B
C
D
E
Asymmetrical. Is the mole or spot that you’ve identified an irregular shape that looks different?
Border. Is the border around the mole or spot irregular or jagged?
Color. Is the color of the mole or spot uneven?
Diameter. Is the mole or spot larger than the size of a pea?
Evolving. Has the mole or spot changed during the past few weeks or months?
“It is important to be familiar with your skin, so you can notice when changes occur,” explained Dr. Trevor Austin, Board-certified medical oncologist and hematologist at Messino Cancer Centers. “Self-skin examinations and routine screening with your physician are the key to early diagnosis. The earlier melanoma is diagnosed the more likely it is to be cured.”
Both types of ultraviolet (UV) rays are emitted from the sun. The Skin Cancer Foundation explains that UVA rays have longer wavelengths and are associated with skin aging, and UVB rays have shorter wavelengths and are associated with skin burning. Despite the different wavelengths, both can contribute to skin cancer.
Here are 11 quick facts about these harmful rays:
1. UVA rays correlate to the “broad-spectrum protection” that is displayed on sunscreen product labels.
2. UVA rays penetrate your skin deeper than UVB rays; however, UVA rays are slightly less intense than their counterparts.
3. UVA radiation is mainly used in tanning beds, which is unsafe.
4. UVA rays can be harmful even if you are inside, as they can penetrate windows and clouds.
5. UVB rays damage the outer layer of skin, cause suntans, sunburns and even blistering.
6. UVB rays are associated with the “SPF or Sun Protection Factor” that is displayed on sunscreen product labels.
7. While UVA rays remain constant, UVB rays fluctuate, meaning they can be more intense in the late morning and mid-afternoon between the spring and fall seasons.
8. UVB rays can be filtered but are unable to penetrate windows.
9. Most non-melanoma skin cancers and a large segment of melanoma diagnoses are from UV radiation exposure from the sun.
10. Damage from UV radiation is cumulative, increasing the risk of skin cancer with each new exposure.
11. Your body cannot heal some of the DNA damage in the skin cells caused by exposure to UV radiation, which can lead to malignant tumors.
There are several myths and misconceptions about skin cancer that can lead to delayed diagnoses and unnecessary anxiety. Here are some of the more prevalent skin cancer myths from the American Cancer Society (ACS) and the AAD so that you can take better care of your skin.
TIMES-CIRCLE Myth: Skin cancer is rare, and not many people are diagnosed with it.
Fact: As mentioned, skin cancer is one of the most common cancers diagnosed. The AAD has reported that about 9,500 people in the United States receive a skin cancer diagnosis every day.
TIMES-CIRCLE Myth: Skin cancer can only be caused by sun exposure.
Fact: While this is a common cause of skin cancer, other factors can lead to this diagnosis. For example, UV exposure from not only the sun but tanning beds and sun lamps are risky. Tanning beds can lead to skin cancer, wrinkles, sunspots, freckles and loss of skin firmness. For this reason, sunless tanning is recommended for those who’d like some color on their skin. The safe thing to remember is that there are no safe UV rays.
TIMES-CIRCLE Myth: Skin cancer only occurs in populations with lighter skin tones.
Fact: Those with lighter skin tones are at higher risk of developing skin cancer, but this does not mean that those who have darker skin complexions do not get diagnosed. Furthermore, it has been found that skin cancer is often discovered at later stages in individuals with darker skin tones because it is not always easily visible.
TIMES-CIRCLE Myth: Skin cancer does not occur for individuals who tan easily.
Fact: This is a popular belief among the larger population. In fact, a tan is a sign of skin damage, and having a tan does not protect your skin from skin cancer or from getting a sunburn, according to the U.S. Food & Drug Administration (FDA). Tanning is the body’s reaction to UVA rays that penetrate the outermost layer of the skin and as a result, darken the skin to prevent further damage.
TIMES-CIRCLE Myth: Skin cancer only occurs in individuals whose routine involves the outdoors.
Fact: Simple, daily activities that expose your skin to the sun can increase your risk of developing skin cancer. Activities such as driving with the sunroof open and walking around outside in the sun, for example, can damage your skin and lead to cancer.
TIMES-CIRCLE Myth: Sunscreen is not needed on a cloudy day.
Fact: Even on gloomy days when the sun is not fully out, its harmful rays pierce through the clouds and can reach your skin. Wearing sunscreen, even on cloudy days, should be a priority to be fully protected.
TIMES-CIRCLE Myth: By wearing sunscreen, you can stay in the sun as long as you want.
Fact: No sunscreen completely shields your skin from the sun, and you should avoid being outside during peak hours when the sun is strongest — between 10:00 a.m. and 4:00 p.m.
• Having a family history of melanoma or other skin cancer. Avoid Getting Burned: A
Sun exposure is widely recognized as the primary culprit behind skin cancer. However, the development is not always solely attributed to spending time in the sun. Here are several lesser-known causes of skin cancer, exploring factors beyond UV rays that can cause the growth of abnormal cells, as explained by the ACS.
• Having a fairer skin tone. This does not mean that those with darker complexions are immune to skin cancer. Lighter-colored skin does not have high levels of melanin, the pigment that develops the skin’s color and provides some protection against the sun.
• Growing older. Older people are at higher risk of skin cancer. This may be because of the sun exposure they have experienced throughout their life, which has built upon over time.
• Being a certain gender. Men are more likely to be diagnosed with basal and squamous cell cancer than women. Again, this may be attributed to this population getting more sun.
• Being exposed to certain harmful chemicals like arsenic. Other chemicals that may increase the risk of skin cancer are coal tar, paraffin and types of petroleum products.
• Having been exposed to radiation from previous treatments.
• Having previously been diagnosed with skin cancer.
• Having a weaker immune system. In this case, the tumor often grows faster and may be more challenging to treat.
• Being diagnosed with the HPV (human papillomavirus) infection. Some HPV types that are found in certain areas of the body can be related to squamous cell cancer.
• Being a frequent smoker.
Trevor Austin, MD MESSINO CANCER CENTERS
What melanoma cancer is and how it can be prevented
Self-examinations of your skin and then consulting a healthcare professional about any discovered abnormalities are the keys to early detection and successfully treating skin cancer. However, despite this knowledge, many people forgo the recommended screenings for various reasons. These obstacles range from a lack of education to misconceptions and access:
• Being unaware of the importance of skin selfexamination and screenings.
• Lacking knowledge about skin cancer.
• Believing tanning and a darker complexion are not harmful and that fair-skinned people are mainly at risk of skin cancer.
• Being fearful of a positive skin cancer diagnosis.
• Not having a dermatologist or primary physician who can emphasize the importance of skin cancer screenings.
• Experiencing uncertainty or a belief about the high costs of seeing a dermatologist for a skin cancer screening and having follow-ups and treatments.
These barriers can deter many people from frequent self-examinations and skin cancer screenings. Still, it must be taught that early detection is paramount in the overall success of a cancer treatment plan. Fortunately, the expertise of dermatologists and oncologists can greatly improve patients’ chances of a positive outcome.
Dermatologists typically analyze suspicious lesions and other skin abnormalities and confirm skin cancer diagnoses, often through biopsies. They can frequently treat these cancers on an outpatient basis. However, for advanced, high risk or rare cases, an oncologist becomes involved.
This new team may include a medical oncologist, surgical oncologist and radiation oncologist, along with a pathologist, care coordination nurse and dietitian, dedicated pharmacists and other specialists to provide comprehensive support throughout the cancer care journey.
Clinical oncology advancements and the use of AI-based software and tools that use machine learning are on the horizon within the industry. With the goal of decreasing diagnostic errors and improving the speed-to-treat timeframe, physicians are becoming more comfortable with AI assisting them in disease detection and diagnosis — serving as an additional tool in these critical stages. In skin cancer detection, advancements are just as evident and being pursued further to enhance the patient experience and overall health outcomes.
Understanding the realities of skin cancer and taking advantage of preventive measures like self-examinations and scheduling routine screenings will minimize your risk of skin cancer and help you enjoy a lifetime of healthy skin.
American Oncology Network Announces the Research Studies Presented at the ASCO 2024 Annual Meeting
AON physicians and leaders present their latest cancer findings with fellow thought leaders at the annual conference.
Learn more
American Oncology Network Expands Radiation Oncology Services, Opens New Clinic
Low Country Radiation in Waycross provides residents access to advanced radiation oncology care.
Learn more
Messino Cancer Centers Strengthens Commitment to Patient Care with New Physician
Board-certified physician Charles Wendling, Jr., MD, joins the physician team.
Learn more
Hematology Oncology Center Adds Xuan Huang, MD, to the Physician Team
Hematology Oncology Center, a partner practice of American Oncology Network, is excited to welcome Board-certified medical oncologist and hematologist Xuan Huang, MD, to its practice, further improving its patient care services and accessibility.
Learn more
American Oncology Network Advances
Karyogram Segmentation and Increases the Speed to Results with New AI Software
American Oncology Network and the AON Central Lab are pleased to announce the implementation of the new cytogenetics AI software HiBand v8.4 for karyogram segmentation and classification. AON Central Lab is the first laboratory in the world to utilize this technology.
Learn more
Local Oncologist Named Advocacy Champion by the Association for Clinical Oncology
Sakeer Hussain, MD, Board-certified medical oncologist at Heartland Oncology & Hematology, a partner practice of the American Oncology Network, was named an Advocacy Champion by the Association for Clinical Oncology (ASCO) during the Association’s 2024 Advocacy Summit in April.
Learn more
The Zangmeister Cancer Center Launches CPAN Chapter to Support Patient Advocacy Efforts
The Zangmeister Cancer Center, a partner practice of American Oncology Network, announced the launch of a local CPAN Chapter to support cancer patients and survivors and patient advocacy efforts.
Learn more
Lone Star Oncology and American Oncology Network Welcome New Board-Certified Physician to Care Team
Lone Star Oncology and American Oncology Network are pleased to announce M. Hassan Sabbagh, MD, has joined the practice’s physician team and is accepting new patients.
Learn more
American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada
American Oncology Network today launched its American Oncology Cares Foundation through its partner practices Hematology Oncology of Indiana in Indianapolis and Hope Cancer Care of Nevada in Las Vegas.
Learn more
Central Georgia Cancer Care Joins American Oncology Network to Elevate Local Cancer Care Delivery
Central Georgia Cancer Care is excited to announce their partnership with the American Oncology Network to further strengthen their patient care and services by utilizing the network’s vast resources and expertise.
Learn more
American Oncology Network Expands to Hawaii, Welcomes New Practice to Network
American Oncology Network is pleased to announce its expansion into Hawaii and welcomes Hawaii Cancer Care to the network.
Learn more
Meaningful Insights Biotech Analytics (MiBA), an innovative healthcare technology company, is pleased to announce its official launch today and its commitment to transforming oncology, research and patient care.
Learn more
American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference
American Oncology Network announced its attendance and panel participation at the annual Community Oncology Alliance (COA) conference from April 4 to April 5 in Orlando, Florida, to further its mission of closing the cancer care gap and ensuring the viability of community oncology.
Learn more
American Oncology Network Expands Footprint in Texas with the Addition of Woodlands Cancer Institute in Houston
American Oncology Network is pleased to announce the opening of Woodlands Cancer Institute and welcomes its physicians to the network.
Learn more
Karen Riley Sawyer, Director Marketing Communications
We are excited to introduce you to Karen Riley Sawyer, our new Director of Marketing Communications who will be managing AON external and internal communications.
Karen has held strategic communications roles in technology and healthcare organizations such as Amazon and Centene Corporation. She holds a J.D. from Gonzaga University School of Law and two B.S. degrees in journalism and communications and sociology from the University of Oregon. She is based in Portland, Oregon, and when she is not working, she can be found enjoying the great outdoors with her family.
Please share your news and stories with her at Karen.Sawyer@AONcology.com.
The work world is constantly evolving and dynamic, requiring you to stay ahead of the curve and learn new skills or knowledge — no matter your role, company or industry. Success hinges on your ability to adapt and evolve as well. Discover how to cultivate a thirst for knowledge to enhance your skillset and propel you toward achieving your professional goals .
CONTINUOUS LEARNING AND LEARNING MINDSET 101
It is proactive development that involves honing your skills, expanding on your current knowledge base and acquiring applicable information for your role, team or company. As the Forbes article “Six Strategies to Build a ‘Learning Mindset’ and Advance Your Career” suggests, it is the process of developing new marketable skills.
POWER-UPS AND PERKS
Continuous learning and a learning mindset yield several benefits, as reported in the Society for Human Resource Management’s (SHRM) article “The Importance of Continuous Learning.”
Personal and professional growth and achievements
Staying relevant in the industry and career field
Being competitive in the market
Being an asset to your company
Job security
Role confidence
Higher job satisfaction
Improved performance
Stronger network
Opportunity to become a thought leader
SHRM and Forbes, along with other resources, recommend ways to cultivate a continuous learning mindset , requiring a shift in perspective but not significant effort:
Embrace diverse perspectives, approaching tasks and conversations with an open mindset.
Practice a growth mindset, not a fixed mindset. This is “the belief that a person’s talents can be developed through hard work, good strategies and input from others” as explained in the Harvard Business Review’s (HBR) article “What Having a ‘Growth Mindset’ Actually Means.”
Prioritize learning by including it on your to-do list or as a quarterly or annual goal.
Seek learning recommendations from your manager, mentor or coach.
Internally pursue mentors within the company who can act as career guides.
Attend and network at industry conferences and events.
Dedicate time to reading industry or skill-specific articles and publications or take courses.
Enroll in professional development programs or formal education programs
Utilize company resources such as AON’s Workday Learning Hub.
Pursuing lifelong learning and a learning mindset are the hallmarks of high-performing individuals. By fostering these qualities, you can thrive in your career and unlock your full potential.
To learn more about continuous learning and other helpful work- and career-related topics, visit AON’s Workday Learning Hub. A variety of courses related to productivity, business skills, communication and personal development, among other topics, are available to help you develop a continuous learning mindset.
VICE PRESIDENT OF CLINICAL INNOVATION
1. How long have you been with AON?
Since July of 2023.
2. What does a “day in the life” look like for you in your role?
I get my two boys (ages 8 and 16) off to their respective schools, finagle some exercise, shower, grab some coffee and then log in for the day. Working remotely has been the biggest change since coming to AON, but my day is usually pretty filled with meetings, reading, planning and preparing.
3. What goals are you and your team working to achieve?
The VBC/quality team is working on enhancing our care coordination efforts to support the network’s practices more effectively and efficiently. There are chronic care management and principal illness reimbursable workflows we will be taking live over the next few months, which has prompted us to select “best-in-class” technology partners. Additionally, we are looking at how best to present actionable data to our providers in a more real-time instance for quality metric capture. We’d love to work toward a networkwide recognized quality program, like ASCOOMH, to really drive home what sets our practices apart from other providers. Our clinical leadership teams are working on increased educational opportunities for our nurses, understanding that investing in our teams is critical to their success. We are working on implementing a Clinical Action Committee, which will focus on improving critical clinical
areas. As our network has seen growth, we must also focus growth on our nursing and APP (advanced practice provider) leadership and are looking at how best to support these roles. Lastly, we are looking at staffing metrics and technology and scheduling solutions to assist in infusion efficiencies.
Our registered dietitian team is growing and focusing more on patient nutrition than ever before. We are hoping to bring in one or two clinical trials on nutrition as a focus of cancer care.
4. How does your role contribute to AON’s overall mission and goals?
AON’s vision to keep patients at the center of everything we do and to close the gaps in care are essential to my role. To me, showing quality and value in cancer care means we are providing the best possible care to ALL patients at the best possible price — and we can PROVE it. Supporting our staff so that they can provide that care is simply common sense.
5. What are you most proud of when it comes to your team and department?
My team gets to focus on patients and outcomes. Every single person on my team genuinely strives to keep the patient experience at the forefront of their scope, whether directly or indirectly. They hold themselves to a higher level than I ever could. Pride is one word; inspired is a better word.
6. What principles guide your work and vision?
The patient must always be the center, and the rest will fall into place. Be positive! Make people smile, it won’t hurt! Sometimes, you should just “shut up and listen.”
7. How do you define the word success?
To me, success is setting a vision, creating goals and working hard as a team to achieve them. We may not always succeed, but we MUST stay positive and have a little fun along the way. Success without joy is too clinical.
8. How do you lead your team? What is your leadership style?
I am a collaborative person; I like to work with my team and get their input. As a style, I would say “transformational.” I try to work with the individual person, because everyone has different motivating factors.
9. What’s your favorite part about working for AON?
AON brings the best of the best together to work toward continuing the successes of community oncology. It is truly an outstanding team, and I am honored to be a spoke in the wheel.
10. What has been the most memorable moment for you while you’ve worked for AON?
Attending the Clinical Summit last year. It was so wonderful to finally get to meet so many teammates in person and watch all the months of planning come to life. While it is a blessing to be able to work remotely, it was fantastic to get to spend time learning in person with everyone.
11. What motivates you to get up and get to work in the morning?
I love my team. I love knowing that they are the best at what they do and that they work hard to get the job done. They inspire me to see how far we can climb.
12. What is a quote you live and/or work by?
“If you can’t explain it simply, you don’t understand it well enough.” - Albert Einstein
13. What are your favorite hobbies outside of work?
Reading, listening to music and hanging out with my kids.
14. What is your favorite book (or books)?
“Atomic Habits” by James Clear.
15. What is a fun fact about you?
As a leukemia survivor, I feel my experience provided profound examples of the patient experience, both good and bad. I would not change one minute of it because I think it led to my deep passion for equitable patientcentric care today.
16. What piece of advice would you give your younger self?
Hang on for the ride; it is SO bumpy, but it is ALWAYS teaching you a valuable lesson. And stop thinking people over 40 are old; they are WISE!!!
17. List three adjectives that describe your personality.
Empathetic, curious and authentic.
18. What is one of your favorite travel destinations, or where do you hope to travel to in your lifetime?
I would like to go to Greece and Iceland someday.
19. Who is your hero?
My parents. I can’t decide between them because they each taught me so much and were always there for me during the best and worst of times.
20. If you had three wishes, what would they be?
Without sounding too idealistic, I would wish for the world to be a better place. Secondly, I wish for my kids to have happy, healthy lives. Third, never-ending chocolate.
SENIOR GRAPHIC DESIGNER
atie joined AON in June 2019 and is the senior graphic designer on the marketing team. Before her current role, she served as a graphic designer.
Katie is responsible for creating visually compelling marketing materials for AON and its network practices, catering to both business-to-business and patient-focused campaigns and initiatives. She enjoys that her job allows for a “unique blend of creativity and purpose.”
“I love the collaborative nature of my work and take satisfaction in the challenge of making information clear and compelling,” she said. “Every project presents a new opportunity to combine design skills to improve healthcare communication and patient experiences.”
AON's mission perfectly aligned with Katie's desire to leverage design for social good. Here, she found a place to combine her passion for graphic design with a mission to help others.
She grew up in rural Florida and understood
Fthe added challenges of long-distance travel for specialized healthcare and advocating for yourself as a patient in larger, impersonal healthcare settings. Katie shared that “AON’s mission to deliver highquality, personalized cancer care in a hometown setting is something I am passionate about and proud to be a part of. It’s rewarding to know that my efforts can potentially make a difference in how patients understand their health or how local oncology practices can impact their communities.”
Outside of work, Katie finds joy in connecting with loved ones over long conversations and shared meals. As a dedicated mother of three, she cherishes witnessing their growth and development. A lifelong learner, Katie fuels her creativity by reading, exploring art, delving into design research, and pursuing courses that enrich her life both professionally and personally. Her perfect balance comes from outdoor activities like swimming, paddleboarding, and spending time with family at their farm.
or 17 years, Brigette has been a key member of the Greater Washington Oncology Associates team, currently serving as their financial counselor and providing invaluable financial guidance to patients. Before taking on this role, she honed her skills in insurance verification at the practice.
“Working in oncology and at the practice has given me the opportunity to learn new skills and expand my knowledge in a field that is
Outside of work, Brigette enjoys spending time with family and friends, playing board games and watching movie nights. But her true passion lies in savoring Maryland blue crabs. FINANCIAL COUNSELOR
constantly changing,” she shared. “What I love about my job is that I meet people from different backgrounds and different cultures. I love being able to help them access quality healthcare, regardless of their circumstances.”
Karen Randall, RDN, CSO, LD Oncology Dietitian
Today, there is significant debate about whether dairy is necessary in our diet. While consuming cow’s milk and other milk-based products has unquestionable benefits, some question whether the positives outweigh the negatives.
In the 1990s, magazine and television commercials frequently featured celebrities sporting milk mustaches. However, despite this famous campaign, individuals have been shifting away from dairy, and dairy alternatives are growing in popularity. What has happened to traditional dairy milk?
Since the 2000s, individuals seeking to lose weight have gravitated toward the Paleo and Ketogenic diets, which largely exclude dairy products. This style of dieting began to raise doubts about the safety of dairy for human consumption.
Milk has 18 of the 22 essential nutrients, making it a nutritional rock star, and as a fluid, it is a simple and efficient way to get many vitamins and minerals. Protein and calcium are the primary nutrients received from milk and dairy products.
Additionally, Americans underconsume 10 essential nutrients, according to the NIH Office of Dietary Supplements. Milk provides three of the four nutrients noted to be of public health concern: calcium, potassium and vitamin D. The fourth is fiber, which is absent in milk. This means that adverse health outcomes are linked to inadequate intake of these nutrients. Of the other six nutrients (vitamins A, E, C, magnesium, iron and choline), milk is a source of vitamin A, magnesium and choline.
What do these nutrients do for our bodies?
• Build strong bones and teeth. Our bodies cannot make calcium, so we must get it from food. Most of us realize the importance of calcium for young, growing children, but it also benefits older adults by reducing the risk of osteoporosis and fractures. An 8-ounce cup of milk provides about 300 milligrams of calcium, depending on the type. This is 25% to 33% of an adult’s daily need of 1000 milligrams to 1200 milligrams.
• High in protein. Milk is one of the only natural, complete protein beverages with 8 grams per cup. Protein builds and repairs cells in our muscles, bones, skin and nails. It also oxygenates our red blood cells, regulates hormones, improves our immune system and aids muscle function, among other benefits.
• Help with managing diabetes. Pairing protein with carbohydrates can help prevent sharp increases in blood sugar. Promising studies are finding that regular intake of low-fat milk or yogurt, which are sources of both carbohydrates and protein, can help manage diabetes.
Consider the options based on your preferences and health goals when choosing milk. There are a few facts for the four most common types of dairy milk reported in 8 ounces or one cup:
The main difference between the types of milk is the amount of fat. The fact that they all contain the same amount of other nutrients is essential. Lower-fat milk, yogurts and cheeses are recommended for overall good health.
Children under 2 are the exception; their developing brains need the fat in whole milk. After age 2, switch to low-fat or continue whole milk, depending on the child’s growth and development.
"Got Milk?" Cow's Milk: Is It Good for You?, continued
What are some concerns that cause people to pause drinking milk?
Cancer and milk: Some studies suggest that drinking large amounts of milk, which is about four or five 8-ounce cups every day, can increase the risk for prostate cancer. Thus, limiting lowfat milk and dairy products to one serving a day is advised for prostate cancer survivors. On the other hand, studies indicate that consuming milk and dairy products can decrease the risk of colorectal and premenopausal breast cancers.
Heart disease and milk: Whole and 2% milks are high in saturated fat, and the risk for heart disease increases with consuming large amounts of saturated fats daily. Newer research suggests that it may not have the negative effects that were previously thought, and if your taste preference is for whole or 2% milk, you should opt for it. Be mindful that if you eat many other foods rich in saturated fats, such as full-fat cheeses, yogurts and milk, reach for the low-fat milk to help keep your intake in check.
Hormones and milk: Milk has growth hormones that can cause early puberty. It’s full of antibiotics, and humans cannot process cow’s milk.
• Experts believe bovine growth hormones do not survive the acidic environment of the gastrointestinal tract or the digestive process and thus have no hormonal activity in humans. Experts believe that if there is an early onset of puberty (as it usually occurs between 8 and 12 years of age), it is linked to genetics, improved nutrition or the prevalence of obesity.
• All milk in grocery stores is antibiotic-free. Strict government standards and protocols exist for milk production, prohibiting milk with antibiotics from being sold in stores.
• Lastly, most of us are equipped with lactase, an enzyme that helps digest lactose, the natural sugar in milk. Lactose-free milk is available for people who have difficulty digesting lactose. Lactose intolerance can be presented as a bloating stomach, gas, stomach gurgling or pain, nausea, and diarrhea. Lactose-free milk is treated with the lactase enzyme, reducing lactose or “predigesting” it, eliminating the symptoms of lactose intolerance. Everything else in lactose-free milk, including the vitamins, minerals, protein and fat, remains the same.
The plant-based eating pattern has gained prominence in recent years, emphasizing a diet where at least two-thirds comes from plant sources like vegetables, fruits, whole grains, beans and plant-based protein. Lean protein sources like chicken, fish and dairy products can make up the remaining one-third or less.
“Got milk?” is still alive and well .
PREPARATION TIME: 5 MIN. // TOTAL TIME: 5 MIN. // SERVES 1
1 cup low-fat milk
1 cup frozen cherries
1/2 cup baby spinach leaves
1 tablespoon salted almond butter
1 (1/2 inch) piece peeled ginger
1 teaspoon chia seeds, plus more for garnish
1/4 cup mashed ripe avocado
1. Place milk in a blender, and add cherries, spinach, avocado, almond butter, ginger and chia seeds.
2. Puree until the mixture is smooth.
3. Pour into a glass and then garnish with more chia seeds, if desired.
NUTRITIONAL INFORMATION:
Serving Size: 13/4 cup Calories: 410; Total Carbohydrates: 47g; Dietary Fiber: 10g; Protein: 17g; Total Fat: 20g; Saturated Fat: 4g; Sodium: 169mg.
For complete recipe and nutrition facts: Eating Well
Receiving a cancer diagnosis brings about uncertainty and fear. However, Jan embraced her cancer diagnosis with calmness, humor and an unwavering desire to continue caring for others. Her journey does not begin in a sterile patient room but in the bustling office of Hammons Hotels, and it was during this time that she had a life-changing encounter with the founder of GYN Cancers Alliance (or GYNCA for short) Joy Lamberson-Klock.
GYNCA, an established nonprofit, was created by a small group of gynecologic cancer patients who understood firsthand the everyday struggles that come with a cancer diagnosis. The
foundation provided a menu of services to women in Southwest Missouri, such as gas money to get to and from treatments and appointments and other essential expenses like support for utilities and rent payments. Jan’s encounter led to her serving on the advisory board of GYNCA, which gave her the ability to champion women battling gynecologic cancers. Upon the passing of GYNCA’s founder, she stepped up to serve as the executive director until her retirement in 2019.
Jan’s life took a turn two years later in the middle of 2021 when a routine mammogram revealed an abnormality in her right breast tissue. Cancer? This was a twist that she had not expected,
but then again, as she had learned, life rarely follows a set script. The initial shock flooded her, but as a pragmatist, she felt a calmness wash over her.
“Having worked with gynecologic cancer patients, I was calm,” she recounts. “For whatever reason, I have always gone ‘calm’ when faced with issues until I know more information and facts. It served me well working with John Q. Hammons for more than 24 years. While the world panicked, I figured things out.”
Cancer was not unknown to Jan personally. While not a medical expert and outside of her experience working with GYNCA, both her mother and grandmother were diagnosed with
breast cancer. However, deciphering her own diagnosis felt like reading a foreign language. Each new term she learned was a piece of a confusing puzzle, and she relied on her humor to handle her new reality.
“I knew minimal information, particularly about the HER2-positive breast cancer,” Jan explained. “My mom had breast cancer in her fifties and with early detection, had only one breast removed, and no radiation, chemotherapy or medications were required during her healing journey. My maternal grandmother passed away from brain and breast cancers. Deep down, I guess, I was aware of the possibility I could receive a similar diagnosis.”
According to the American Cancer Society, HER2-positive breast cancer is a result of higher levels of protein that can grow at an accelerated rate. Regular screenings can detect breast cancer early and sometimes up to three years before it can be felt, as reported by the Centers for Disease Control and Prevention.
Jan’s guiding light was Dr. Brooke Gillett, a Board-certified medical oncologist at Oncology Hematology Associates (OHA), a communitybased oncology practice with three clinic locations in Missouri (Springfield-Lebanon-Monett).
OHA is staffed by a team of skilled, compassionate Board-certified physicians who help patients receive
care close to home.
Jan went on to share, “My surgeon from CoxHealth and his nurse navigator recommended several oncologists, including the OHA group. OHA contacted me and suggested Dr. Gillett as a capable breast cancer oncologist. I was grateful for the suggestion because I was able to see her within a few days. As it turns out, Dr. Gillett practiced at the Huntsman Cancer Institute at the University of Utah. Having grown up in Utah, it was a great choice. Dr. Gillett has been a great fit for me, and those I’ve recommended see her are pleased as well.”
On the day of her first oncology appointment at OHA, Jan felt an immediate sense of comfort upon entering the office.
“From the minute I walked into the OHA office, I felt welcomed,” she reflected. “I have always been greeted with open arms and formed some awesome relationships with the lab techs, scheduling team, doctors, nurses, infusion team and even the volunteers who passed out blankets throughout my healing journey.”
Dr. Gillett explained that “Jan came to our office with invasive lobular carcinoma involving her right breast, which was stage 1, estrogen receptor-positive and HER2-positive diagnosed in June 2021. She had a very positive attitude from the start, and her prognosis is very good.”
"From the minute I walked into the OHA office, I felt welcomed."
Brooke Gillett, DO ONCOLOGY HEMATOLOGY ASSOCIATES
HER2-positive breast cancer is more aggressive than other types of breast cancer and causes breast cells to grow and divide uncontrollably.
Patient Story: Jan, continued
Jan’s personalized treatment journey, created by Dr. Gillett, included 11 months of adjuvant chemotherapy to prevent recurrence after she completed bilateral mastectomies.
“We planned on 12 weeks of Taxol in combination with Herceptin,” said Dr. Gillett. “Taxol was discontinued after 10 weeks due to peripheral neuropathy, but otherwise, she tolerated the treatments well. She stayed on Herceptin until August 2022 to complete one full year of therapy. Jan also started endocrine therapy with letrozole during her treatment and continues to take it now. She is doing very well on this treatment plan.”
Over the months of Jan’s treatments, she got to know not only the care team at OHA but also her fellow cancer warriors. They became like family to her.
“I found some Longmire (the TV show) fans who were staffers and brought them Longmire shirts, and I still wander the halls and infusion rooms looking for my favorites to see how they and their kids are doing,” Jan said. “I just love this group! And when it came time to ring the bell, several of these angels were right there with me.”
Jan celebrated the conclusion of the chemotherapy treatments on August 3, 2022.
“[Jan] didn’t want to make a big fuss at her last chemo treatment, but so many people wanted to help her celebrate,” shared Jan’s daughter Kim. “I asked friends and family if they’d like to contribute to her by paying it forward to the future patients of OHA. So many people contributed money, and I made a huge snack run to Sam’s. [Jan] just thought I was bringing a Walmart bag of snacks, but I rolled in with a wagon full of them. She was laughing and simultaneously crying at the generosity of her family and friends.”
Following her cancer diagnosis, Jan rejoined GYNCA as executive director in January 2023, having continued to occasionally volunteer for the organization during her fouryear absence.
“GYNCA needed me at the time, and I think I needed GYNCA again,” Jan smiled. “I liken it to a God wink! Unretiring and getting back to work at GYNCA as a survivor myself
Note: Cancer patient outcomes and experiences may vary, even for those with the same type of cancer. An individual patient’s story should not be used as a prediction of how another patient will respond to treatment.
gives me a whole new perspective and understanding of what patients are facing — and it gives them hope to see me as a survivor. My presence as a cancer survivor, I believe, offers hope to many who are just beginning their treatment journey. In turn, it has clarified for me my purpose and intention. It was not long ago that I finally cried when I saw a picture of bald Jan in full chemo mode; it was a healing journey in and of itself. The good news is that my humor is still pretty wicked, and I try to extend at least one kindness to a total stranger each and every day.”
When asked what she has learned during her cancer journey, Jan explained, “Ask and then accept help and don’t feel guilty about it! My daughter and dear friend, Janell, got me over the hump on this one; I was so weak from chemo treatments that I just caved and needed assistance. Once I let go of the premise that I could do it all by myself, it was remarkable. Caregivers and family are always ready to step up with a meal, errands or transportation, so please do the hard thing — ask! Otherwise, they feel helpless. My care team rocked!”
Jan’s story starts with a cancer diagnosis but ends with a powerful reminder of the human connection that binds all. In addition to being a mother, she is a grandmother to four rambunctious grandsons, who call her YaYa, and thankful she can continue to be in their lives.
As the number of individuals who are diagnosed with cancer increases, the funds available to financially support them decreases. American Oncology Cares provides financial support to assist qualified adult cancer patients undergoing treatment with non-medical expenses. By alleviating some of the financial burden associated with essential living expenses like rent or mortgage, utilities, transportation, and food, patients can focus more on healing and getting better rather than finances and bills.
Search Program Overview
• Program launched October 2023
• AON contracted with nonprofit America’s Charities to administer and manage American Oncology Cares
• America’s Charities responsible for patient application review and distribution of patient grants
• Monies raised in your state, benefit patients in your state
user-plus Patient Eligibility
• Active cancer treatment
• Over 18 years old
• Household income at or below 200% of the U.S. Federal Poverty Guidelines
• Complete online application
• Housing expenses, utility bills (gas, water and electric), and transportation and food costs associated with travel for cancer treatments
• Applicants can apply to receive one grant of up to $750 per year
Program Criteria for Your Practice/State
• Please contact Kembly.Mourelo@AONcology.com
Imagine a world where clinical innovations meet inspiration and where networking with like-minded oncologists and healthcare leaders is more than just a handshake with a friendly “Howdy do.” Welcome to AON’s Clinical Summit 2024: Pioneering New Frontiers, set in the vibrant city of Dallas, Texas, from November 15 through November 16 at The Ritz-Carlton Dallas, Las Colinas.
Register now for Clinical Summit 2024 and prepare for an immersive weekend that promises to be as big and bold as the Lone Star State itself.
